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An artificial conjugate of the heavy chain of tetanus toxin linked by a disulphide bond to the impermeant ribosome-inactivating protein gelonin 
is cytotoxic to intact HT29 cells by inhibiting intracellular protein synthesis. Neither toxin nor gelonin alone has any significant effect. This shows 
that the heavy chain has the ability to mediate internalization of a protein to which it is bound by a disulphide bond. Thus the normal role of 
the tetanus toxin heavy chain may be to allow entry of the light chain into a cell. 
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1. INTRODUCTION 
Tetanus toxin is a neurotoxin secreted by 
Clostridium tetani, and is the main causative agent of 
tetanus, a spastic paralysis of the muscles. Although 
the mode of action of the toxin is understood at the 
physiological level - it is retrogradely transported up 
the motor axon from the neuromuscular junction, then 
crosses into inhibitory presynaptic neurons where it 
prevents neurotransmitter release - little is known 
about its action at the molecular level. 
The intact molecule is a single polypeptide chain (Mr 
150000) with an internal disulphide bond. Subsequent 
proteolytic cleavage means that the toxin is usually 
found as a 100 kDa (heavy or H) chain joined to a 
50 kDa (light or L) chain by a single disulphide bond 
[ 1,2]. This two-component structure is common to a 
number of bacterial toxins such as cholera [3] and 
diphtheria [4]. In the case of these latter toxins, one 
component binds to the target cell, and is followed by 
the entry of the other component into the cell where it 
catalyses a reaction leading to toxicity. A current model 
[5] suggests that tetanus toxin may work in a similar 
manner. Binding of the heavy chain to gangliosides and 
possibly other receptors on the cell surface is well 
established [1,2], but it is not known if it has any role 
during the entry of the light chain into the cell. The ‘ef- 
fector’ function of the light chain is even less clear-cut. 
Ahnert-Hilger et al. [6] have shown inhibition of 
catecholamine release from permeabilised adrenal 
chromaffin cells after treatment with the light chain of 
tetanus toxin alone or with the two-chain form in the 
presence of a reducing agent. Similar activities of the 
light chains of tetanus and of botulinum toxins (which 
are thought to have similar molecular mechanisms) 
have also been reported in other systems [7,8]. On the 
other hand, Poulain et al. [9], working on Apiysia, 
reported that both the light and the heavy chains of 
botulinum toxin need to enter the cell before an effect 
is observed. 
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In the present study this question was addressed by 
the use of a hybrid toxin. The isolated heavy chain of 
tetanus toxin was conjugated to gelonin, a cell- 
impermeant analogue of the A-chain of ricin that in- 
hibits ribosomal protein synthesis [9). Although 
gelonin itself was minimally toxic to a cultured cell line, 
the gelonin/heavy-chain conjugate showed con- 
siderable toxicity, associated with a reduced level of 
protein synthesis by the target cells. This demonstrates 
that the tetanus toxin heavy chain, linked to another 
polypeptide by a disulphide bond, is capable of 
mediating the entry into cells of that polypeptide. Once 
internalised, the polypeptide is then free to act in its 
usual manner. These observations confirm the binding 
function of the tetanus toxin heavy chain, and, more 
importantly, suggest hat the heavy chain could also 
facilitate the entry into cells of another disulphide- 
linked polypeptide, namely, the light chain of the toxin. 
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2. MATERIALS AND METHODS 
2. I. I;roia:ion of heavy chain 
Tetanus toxin and its chains were prepared from a freeze-dried 
crude sample of an ammonium sulphate precipitate of lysed 
Clostridium tetani cells kindly supplied by Dr N. Fairweather of 
Wellcome Biotech. The toxin was further purified by ion-exchange 
chromatography [ 111, then tryptically cleaved to form the heavy and 
light chains still joined by a disulphide bridge. This material was then 
subjected to polyacrylamide gel electrophoresis under reducing con- 
ditions and the individual chains subs~uen~y purified by electroelu- 
tion into 10 mM sodium phosphate buffer, pH 7.4, containing 0.05% 
(w/v) SDS. (The detergent was included because tetanus H-chain has 
been shown to bind readily to dialysis membrane and to come out of 
solution at high concentrations.) 
2.2. Preparation of heavy chain/gefonin conjugate 
This was achieved by mixing a PDP-derivative of tetanus H-chain 
with a reduced PDP-derivative of gelonin, based on the methods of 
Carlsson et al. [12]. A small amount of ‘2SI-labelled gelonin and 
0.25 mg unlabelled gelonin in 1 ml borate buffer (50 mM sodium 
tetraborate, 300 mM NaCl, 0.5% butanol, pH 9) was mixed with 
40 ,ul SPDP (6 mg/ml in DMSG). The reaction was allowed to pro- 
ceed for 30 min at room temperature and the products dialysed over- 
night against acetate buffer (100 mM sodium acetate, 100 mM NaCl, 
1 mM EDTA, pH 4.5). The dialysed material was then reduced by 
addition of 2 mg dithiothreitol (DTT). After 30 min at room 
temperature, excess DTT was removed by passage through a 
Sephadex G25 column equilibrated with phosphate buffer (100 mM 
sodium phosphate, 100 mM NaCl, 1 mM EDTA, pH 7.3). PDP-H- 
chain was prepared in a similar manner using 0.5 mg electroeluted H- 
chain and 40 ~120 mM SPDP. In this case no reduction step was in- 
cluded and the excess SPDP was removed on a Sephadex G2S col- 
umn. PDP-H-chain was mixed with reduced PDP-gelonin for 48 h at 
room temperature, and the solution concentrated by Amicon filtra- 
tion before separation on a Sephacryl S200 column equilibrated with 
borate buffer. Fractions containing the unreacted gelonin were 
discarded. The remaining material was lyophilised, resuspended in 
deionised water then dialysed against lbfold diluted PBS. Finally, 
the material was lyophilised, then redissolved in RPMI/lO~o FCS 
and Millipore-filtered (0.22 ,um) before addition to cultured cells. 
2.3. Cytotoxicity of conjugates 
The cytotoxicity of toxins and derivatives was determined using the 
human colonic carcinoma cell line HT29. These cells were plated in 
200 pi RPMI 1640 m~ium/lO~o foetal calf serum at a density of 4 x 
lo3 per well in a 96-well culture plate, allowed to reach log-growth 
stage (36 h), then treated with the test sample (20 ~1 added) over the 
following 72 h. Cell viability was then measured using the MTT assay 
of Carmichael et al. [13]. Briefly, to each well containing 200 ml of 
medium was added 50rl of 2 mg/ml MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetr~olium blue). The 
plate was returned to the incubator for a fnrther 3.5 h, after which 
the medium and MTT were removed (taking care not to dislodge the 
cells) and the blue formazan reaction product dissolved by adding 
100 ~1 dimethylsulphoxide toeach well. The absorbance at 570 nm of 
each well was measured on an ELISA plate reader; this value was 
proportional to the number of living cells in the well. Control ex- 
periments to establish the ability of this assay to indicate cytotoxicity 
were carried out using cycloheximide, ricin and diphtheria toxin as 
the cytotoxie agents. 
The effects of toxin and conjugates on cellular protein synthesis 
were determined according to the method described by Draper and 
Simon [14]. The medium was removed from the cells (either treated 
or untreated) and replaced with RPM1 deficient in L-leucine. After 
2 h, 1 ,&i [sH]L-leucine was added and the plates returned to the in- 
cubator for 1 h. The cells were next washed twice with 0.05 M 
phosphate buffer, 0.15 M NaCl, pH 7.2, containing 1 mglml 
unlabelled leucine, then solubilised in this buffer containing 0.05% 
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Fig. 1. Effect of various cytotoxins (ricin, diphtheria toxin or 
cycloheximide) on the viability of intact HT29 cells as measured by 
the MTT assay as described in the text. 100% = absorbance at 
570 nm of formazan product in wells to which no cytotoxic agent was 
added. 
SDS, 1 mg/ml DNase-1, 1 mM CaCl2 and 1 mM MgCl2. Aliquots 
were transferred to numbered Whatman GF/C filters, soaked in 5% 
trichloroacetic acid for 30 min, then washed twice with 95% ethanol. 
After drying, the filters were assayed for radioactivity by scintillation 
counting. Cytotoxicity and protein synthesis assays were performed 
in triplicate wells. 
3. RESULTS AND DISCUSSION 
The results of the cytotoxicity experiments are 
presented in Figs l-3. Fig. 1 shows the use of the MTT 
assay to demonstrate that the survival of HT29 cells 
after a 72 h exposure to each of 3 different cytotoxic 
agents (ricin, diphtheria toxin, or cycloheximide) was 
reduced to 35-40070 of the control value in a manner 
dependent on dose over several orders of magnitude 
from less than nanograms to more than milligrams per 
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Fig. 2. Effect of tetanus toxin and of gelonin on the viability of intact 
HT29 cells. 100% is as described in the legend to Fig. 1. 
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Fig. 3. Effect of the gelonin/heavy-chin conjugate on the viability 
of intact HT29 cells. 100% is as described in the legend to Fig. 1. 
ml. Fig. 2 illustrates the effects of treatment of the cells 
with a solution of whole tetanus toxin. This toxin solu- 
tion did kill about 20% of the cells, but since the con- 
centrations used were much higher than those of Fig. 1, 
and there was no apparent dependency on dose, it 
seems likely that cell death was not due to the toxin 
molecule itself. Simil~ly, as also shown in Fig. 2, 
gelonin was only weakly cytotoxic and showed little 
dose-dependence, 
In contrast, when various dilutions of the 
gelonin/heavy-chain conjugate were tested, cell sur- 
vival ranged from 78% down to approximately 15% in 
a dose-dependent fashion, as shown in Fig. 3. This 
cytotoxicity was associated with a dose-dependent in- 
hibition of protein synthesis to less than 20% of the 
control value (Fig. 4). The absolute concentration of 
conjugate used in these experiments could not be deter- 
mined because the amounts involved were below the 
sensitivity threshold of the protein assay. A crude 
estimate of the maximum amount present, based on 
silver or Coomassie blue staining of polyacrylamide 
gels, shows that the concentration of the undiluted con- 
jugate must have been less than 0.4pg/ml, implying 
that the highest concentration tested in the cytotoxicity 
assay was less than 8 ng/ml. Control experiments using 
RPMI/FCS or sodium phosphate buffer, without any 
putative cytotoxin, indicated that addition of these 
diluents to the cultures did not cause cell death (data 
not shown). 
These results indicate that the heavy chain of tetanus 
toxin, as part of a disulphide-inked hybrid toxin, was 
able to facilitate the internalization of the non-tetanus 
component of the hybrid. The internalized species was 
then able to bring about cell death by inhibition of 
cellular protein synthesis. Since neither gelonin (with 
intact cells) nor tetanus toxin (with intact or 
permeabilized cells) can have this activity, we suggest 
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Fig. 4. Effect of the gelonin/heavy-chain conjugate on protein 
synthesis in HT29 cells as described in the text. 100% = TCA- 
precipitable counts from wells to which no conjugate was added. 
that the hybrid gelonin/heavy-chain conjugate can 
mimic the native two-chain tetanus toxin molecule, and 
that our results support the model of toxin action in 
which the heavy chain in some way allows entry into the 
cell of the light chain. Once inside, the light chain can 
then proceed to interfere with normal synaptic 
transmission. 
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